Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 2671-2680 Newer>

Managed Care January 2006 MargaretAnn Cross	Case Management Meets Home Care Aetna incorporates a program developed at the University of Pennsylvania to deliver services where members live.
Managed Care January 2006 Martin Sipkoff	Skeptics Abound as Demand Grows For Obesity Treatments Changes in reimbursement patterns for obesity drugs will take several years. Lifestyle changes remain the first approach.
Managed Care January 2006	Compensation Monitor A recent poll reveals that doctors distrust pay for performance programs.
Managed Care January 2006	The Formulary Files The Pharmacy Benefit Management Institute reports an increase in drug margins.
The Motley Fool January 31, 2006 Stephen D. Simpson	Wyeth: Waiting on the Pipeline While Wyeth's growth today is modest, the late-stage pipeline could pay off. Investors, take note.
The Motley Fool January 31, 2006 John Bluis	Affymetrix: Far, Far Array Investors who enjoy companies that are consistent with guidance may have some interest in this company that provides tools for use in genomics-related research. Unfortunately, this year the consistency was in reporting disappointing results.
Information Today January 30, 2006 Paula J. Hane	ProQuest Decides That Evidence Matters Medical professionals - and their patients - should welcome online medical search subscription services such as ProQuest.
The Motley Fool January 30, 2006 Stephen D. Simpson	Don't Hold Your Breath for Kensey Nash It's not over for Kensey Nash -- it will soon be seeing revenue from new partners Medtronic and Zimmer. But the stock's price continues to value this company as a growing med-tech idea.
The Motley Fool January 30, 2006 Stephen D. Simpson	Respironics in Thin Air Respironics has a great business in the sleep apnea duopoly, but it's still expensive. Investors, take note.
The Motley Fool January 30, 2006 Stephen D. Simpson	Healing Growth for Kinetic Concepts Reimbursement and competition are becoming bigger threats, but the wound-care specialist is still a leader in a large market. Investors may want to put this one high up on their watch lists.
<Older 2671-2680 Newer> Return to current articles.